{
  "ticker": "UBI",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02972369",
  "id": "02972369",
  "pages": 6,
  "price_sensitive": true,
  "date": "20250724",
  "time": "1405",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250724/pdf/06m3f3qh196wqj.pdf",
  "summary": "### **Universal Biosensors, Inc. \u2013 June 2025 Quarterly Report (Appendix 4C) Summary**  \n\n#### **Financial Highlights**  \n- **Cash & cash equivalents (30 June 2025):** **$2.55M** (down from $4.92M previous quarter).  \n- **Net operating cash outflow:** **-$2.13M** (improved by $1.59M vs. Q1 2025).  \n- **Government grants received:** **$2.20M** (quarterly).  \n- **Debt repayments:** **$255K** (quarterly); total borrowings outstanding: **$355K** (secured collateral).  \n\n#### **Funding & Liquidity**  \n- **Estimated funding runway:** **1.2 quarters** (based on current burn rate).  \n- **Capital raising plans:** Discussions ongoing (referenced ASX release 2 July 2025).  \n\n#### **Operational Update**  \n- Focus on commercialization of core products:  \n  - **Xprecia** (blood coagulation testing), **Sentia** (wine analytics), **Aquascout** (water heavy metal testing).  \n\n**No material new capex, dividends, or M&A activity disclosed.**  \n\n---  \n**Brevity note:** Excluded non-material details (e.g., director fees, FX impacts). Liquidity risk flagged due to short funding runway.",
  "usage": {
    "prompt_tokens": 3395,
    "completion_tokens": 293,
    "total_tokens": 3688,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-24T04:14:31.892307"
}